Discovery and significance of protein-protein interactions in health and disease

被引:5
|
作者
Greenblatt, Jack F. [1 ,2 ]
Alberts, Bruce M. [3 ]
Krogan, Nevan J. [4 ,5 ,6 ]
机构
[1] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada
[3] Univ Calif San Francisco UCSF, Dept Biochem & Biophys, San Francisco, CA USA
[4] Univ Calif San Francisco UCSF, Quantitat Biosci Inst, San Francisco, CA 94143 USA
[5] J David Gladstone Inst, Gladstone Inst Data Sci & Biotechnol, San Francisco, CA 94158 USA
[6] Univ Calif San Francisco UCSF, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
ANTI-TERMINATION PROTEIN; NUSA GENE PROTEIN; ESCHERICHIA-COLI; MASS-SPECTROMETRY; RNA-POLYMERASE; INTERACTION NETWORK; CROSS-LINKING; AFFINITY PURIFICATION; TRANSCRIPTION ANTITERMINATION; SACCHAROMYCES-CEREVISIAE;
D O I
10.1016/j.cell.2024.10.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The identification of individual protein-protein interactions (PPIs) began more than 40 years ago, using protein affinity chromatography and antibody co-immunoprecipitation. As new technologies emerged, analysis of PPIs increased to a genome-wide scale with the introduction of intracellular tagging methods, affinity purification (AP) followed by mass spectrometry (MS), and co-fractionation MS (CF-MS). Now, combining the resulting catalogs of interactions with complementary methods, including crosslinking MS (XL-MS) and cryogenic electron microscopy (cryo-EM), helps distinguish direct interactions from indirect ones within the same or between different protein complexes. These powerful approaches and the promise of artificial intelligence applications like AlphaFold herald a future where PPIs and protein complexes, including energy-driven protein machines, will be understood in exquisite detail, unlocking new insights in the contexts of both basic biology and disease.
引用
收藏
页码:6501 / 6517
页数:17
相关论文
共 50 条
  • [1] Protein-protein interactions in drug discovery
    Sankar, U
    GENETIC ENGINEERING NEWS, 2005, 25 (05): : 30 - +
  • [2] The pharmacological significance of protein-protein interactions
    Barnes, NM
    Brady, CA
    Dawlatly, S
    Lin, L
    Williams, JM
    Hope, AG
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U135 - U135
  • [3] Stabilization of protein-protein interactions in drug discovery
    Andrei, Sebastian A.
    Sijbesma, Eline
    Hann, Michael
    Davis, Jeremy
    O'Mahony, Gavin
    Perry, Matthew W. D.
    Karawajczyk, Anna
    Eickhoff, Jan
    Brunsveld, Luc
    Doveston, Richard G.
    Milroy, Lech-Gustav
    Ottmann, Christian
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (09) : 925 - 940
  • [4] Protein microarrays as a discovery tool for studying protein-protein interactions
    Korf, U
    Wiemann, S
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (01) : 13 - 26
  • [5] Protein-protein interactions (PPIs) and disease
    Duesbury, M.
    FEBS JOURNAL, 2010, 277 : 149 - 149
  • [6] Protein-protein interactions in human disease
    Ryan, DP
    Matthews, JM
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2005, 15 (04) : 441 - 446
  • [7] Databases of protein-protein interactions and their use in drug discovery
    Fuentes, Gloria
    Oyarzabal, Julen
    Rojas, Ana M.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (03) : 358 - 366
  • [8] Editorial: Protein-Protein Interactions: Drug Discovery for the Future
    Rapposelli, Simona
    Gaudio, Eugenio
    Bertozzi, Fabio
    Gul, Sheraz
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [9] Structural biology and drug discovery for protein-protein interactions
    Jubb, Harry
    Higueruelo, Alicia P.
    Winter, Anja
    Blundell, Tom L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 241 - 248
  • [10] Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals
    Yadav S.
    Liu J.
    Scherer T.M.
    Gokarn Y.
    Demeule B.
    Kanai S.
    Andya J.D.
    Shire S.J.
    Biophysical Reviews, 2013, 5 (2) : 121 - 136